Live

rare oncology

2 articles

Rare Cancer Drug Market Surges 7.3% Annually as Novel Therapies Transform PCPG Treatment

GlobeNewswire Inc.

GlobeNewswire Inc.·Apr 20·Delveinsight

Rare Cancer Drug Market Surges 7.3% Annually as Novel Therapies Transform PCPG Treatment

PCPG cancer market projects 7.3% annual growth through 2036, valued at USD 300M in 2025, driven by novel drug classes and Novartis WELIREG leadership.

MRKNVSBHCCATXJAZZmarket growthradioligand therapy

Servier Acquires Day One Biopharmaceuticals for $2.5B to Bolster Rare Oncology Pipeline

Benzinga

Benzinga·Mar 6·Globe Newswire

Servier Acquires Day One Biopharmaceuticals for $2.5B to Bolster Rare Oncology Pipeline

Servier acquires Day One Biopharmaceuticals for $2.5B in cash, expanding rare pediatric oncology portfolio with closing expected Q2 2026.

DAWNacquisitionbiopharmaceutical